Importance of sarcopenia parameter changes after living donor liver transplantation.
作者信息
Pagano Duilio, Barbieri Letizia, Seidita Aurelio, Gruttadauria Salvatore
机构信息
Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, Abdominal Surgery and Organ Transplant Unit, IRCCS-ISMETT, University of Pittsburgh Medical Center (UPMC) Italy, Palermo, Italy.
Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, Hepatology Unit, IRCCS-ISMETT, UPMC Italy, Palermo, Italy.
出版信息
Hepatobiliary Surg Nutr. 2017 Jun;6(3):193-195. doi: 10.21037/hbsn.2017.03.11.
Abstract
摘要
相似文献
1
Importance of sarcopenia parameter changes after living donor liver transplantation.活体肝移植后肌肉减少症参数变化的重要性。
Hepatobiliary Surg Nutr. 2017 Jun;6(3):193-195. doi: 10.21037/hbsn.2017.03.11.
2
Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.活体肝移植前肌肉减少症的影响及肌肉减少症参数在移植后的变化
Nutrition. 2017 Jan;33:195-198. doi: 10.1016/j.nut.2016.07.002. Epub 2016 Jul 27.
3
Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Clin Nutr. 2019 Apr;38(2):964-965. doi: 10.1016/j.clnu.2019.01.026. Epub 2019 Feb 1.
4
Serum Tumor Necrosis Factor-α Is Inversely Associated With the Psoas Muscle Index in Both Male and Female Patients Scheduled for Living Donor Liver Transplantation.血清肿瘤坏死因子-α与计划进行活体肝移植的男性和女性患者的腰大肌指数呈负相关。
Transplant Proc. 2019 Jul-Aug;51(6):1874-1879. doi: 10.1016/j.transproceed.2019.03.034. Epub 2019 Jun 28.
5
Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.肌肉减少症作为米兰标准以外的肝癌患者活体肝移植后肿瘤复发的预测因素。
Sci Rep. 2018 May 8;8(1):7157. doi: 10.1038/s41598-018-25628-w.
6
Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation.活体肝移植后低肌肉量受者急性细胞排斥反应发生率降低
Transplant Proc. 2018 Dec;50(10):3626-3634. doi: 10.1016/j.transproceed.2018.06.028. Epub 2018 Jun 30.
7
Sarcopenia is a prognostic factor in living donor liver transplantation.肌肉减少症是活体肝移植中的一个预后因素。
Liver Transpl. 2014 Apr;20(4):401-7. doi: 10.1002/lt.23811. Epub 2014 Jan 27.
8
Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition.活体肝移植患者血浆氨基酸值作为脓毒症预测指标的概况：特别提及肌肉减少症和术后早期营养
Hepatol Res. 2015 Dec;45(12):1170-7. doi: 10.1111/hepr.12484. Epub 2015 Mar 3.
9
Sarcopenia and chronic liver diseases.肌肉减少症与慢性肝脏疾病。
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1229-1244. doi: 10.1080/17474124.2018.1534586. Epub 2018 Oct 16.
10
Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.致编辑的回信——肌少症肥胖对活体肝移植患者预后的影响
Clin Nutr. 2019 Apr;38(2):967. doi: 10.1016/j.clnu.2019.01.024. Epub 2019 Feb 1.
引用本文的文献
1
Geriatric nutritional risk index serves as risk factor of surgical site infection after pancreatoduodenectomy: a validation cohort Ageo study.老年营养风险指数是胰十二指肠切除术后手术部位感染的危险因素：一项验证队列Ageo研究。
Gland Surg. 2020 Dec;9(6):1982-1988. doi: 10.21037/gs-20-451.
本文引用的文献
1
Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.活体肝移植前肌肉减少症的影响及肌肉减少症参数在移植后的变化
Nutrition. 2017 Jan;33:195-198. doi: 10.1016/j.nut.2016.07.002. Epub 2016 Jul 27.
2
Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.肌肉-MELD 评分的提出，包括肌肉质量，用于预测活体肝移植后死亡率。
Transplantation. 2016 Nov;100(11):2416-2423. doi: 10.1097/TP.0000000000001413.
3
Physical activity and liver diseases.体力活动与肝脏疾病。
Hepatology. 2016 Mar;63(3):1026-40. doi: 10.1002/hep.28132. Epub 2015 Dec 18.
4
Liver transplantation arrests and reverses muscle wasting.肝移植可阻止并逆转肌肉萎缩。
Clin Transplant. 2015 Mar;29(3):216-21. doi: 10.1111/ctr.12506. Epub 2015 Jan 27.
5
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.亚洲肌少症共识报告：亚洲肌少症工作组报告
J Am Med Dir Assoc. 2014 Feb;15(2):95-101. doi: 10.1016/j.jamda.2013.11.025.
6
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.肝硬化患者肝移植术后的肌肉减少症：一项前瞻性评估。
J Gastroenterol Hepatol. 2014 Jun;29(6):1250-7. doi: 10.1111/jgh.12524.
7
Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism.肝硬化中的血氨过多通过 NF-κB 介导的机制诱导肌肉生长抑制素的转录调节。
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18162-7. doi: 10.1073/pnas.1317049110. Epub 2013 Oct 21.
8
Comment on "Impact of sarcopenia on survival in patients undergoing living donor liver transplantation".关于《肌肉减少症对活体肝移植患者生存的影响》的评论
Am J Transplant. 2013 Sep;13(9):2505. doi: 10.1111/ajt.12375. Epub 2013 Aug 5.
9
Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.肌肉减少症对活体供肝移植患者生存的影响。
Am J Transplant. 2013 Jun;13(6):1549-56. doi: 10.1111/ajt.12221. Epub 2013 Apr 19.
10
Pre- and perioperative factors affecting infection after living donor liver transplantation.影响活体肝移植术后感染的术前和围手术期因素。
Nutrition. 2012 Nov-Dec;28(11-12):1104-8. doi: 10.1016/j.nut.2012.02.007.
Zotero 插件